clinical trial; Hepatitis B; hepatocellular; therapeutics; vaccine

Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature Reviews Gastroenterology & Hepatology. 2023; 20(8): 524-537. doi: 10.1038/s41575-023-00760-9 Cao G, Jing W, Liu J, et al. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatology International. 2021; 15(5): 1068-1082. doi: 10.1007/s12072-021-10232-4 Patel A, Dossaji Z, Gupta K, et al. The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus. Gastro Hep Advances. 2024; 3(2): 139-150. doi: 10.1016/j.gastha.2023.10.008 Alberts C, Clifford G, Georges D, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. The Lancet Gastroenterology & Hepatology. 2022. doi: 10.1016/S2468-1253(22)00050-4 Duberg A, Lybeck C, Fält A, et al. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study. Hepatology Communications. 2022; 6(9): 2418-2430. doi: 10.1002/hep4.1974 Bollerup S, Hallager S, Engsig F, et al. Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark. Journal of Viral Hepatitis. 2022; 29(9): 727-736. doi: 10.1111/jvh.13713 Hudu AS, Malik Y, Taib N, et al. Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Preference and Adherence. 2013. doi: 10.2147/ppa.s49776 Su J, Brunner L, Ates Oz E, et al. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. Journal of Hepatology. 2023; 78(4): 717-730. doi: 10.1016/j.jhep.2022.12.013 de Morais Pinto R, de Medeiros Valentim RA, Fernandes da Silva L, et al. Analyzing the reach of public health campaigns based on multidimensional aspects: the case of the syphilis epidemic in Brazil. BMC Public Health. 2021; 21(1). doi: 10.1186/s12889-021-11588-w Smith-Palmer J, Cerri K, Sbarigia U, et al. Impact of Stigma on People Living with Chronic Hepatitis B. Patient Related Outcome Measures. 2020; 11: 95-107. doi: 10.2147/prom.s226936 Martyn E, Eisen S, Longley N, et al. The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda. eLife. 2023; 12. doi: 10.7554/elife.81070 Hudu S, Jimoh A, Ibrahim K, et al. Hepatitis B Therapeutic Vaccine: A Patent Review. Pharmaceuticals. 2022; 15(12): 1542. doi: 10.3390/ph15121542 Phillips S, Jagatia R, Chokshi S. Novel therapeutic strategies for chronic hepatitis B. Virulence. 2022; 13(1): 1111-1132. doi: 10.1080/21505594.2022.2093444 Jiang N, Malone M, Chizari S. Antigen‐specific and cross‐reactive T cells in protection and disease. Immunological Reviews. 2023; 316(1): 120-135. doi: 10.1111/imr.13217 Takahama S, Yoshio S, Masuta Y, et al. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality. Frontiers in Immunology. 2023; 14. doi: 10.3389/fimmu.2023.1257113 Hudu SA. Cell Culture, Technology: Enhancing the Culture of Diagnosing Human Diseases. Journal of Clinical and Diagnostic Research. 2016. doi: 10.7860/jcdr/2016/15837.7460 Hudu SA, Shinkafi SH, Umar S, et al. Reverse Vaccinology Approach for a Potential Rhinovirus Vaccine. Avicenna Journal of Clinical Microbiology and Infection. 2021; 8(2): 66-73. doi: 10.34172/ajcmi.2021.12 Farhad T, Neves K, Arbuthnot P, et al. Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics. Genes. 2022; 13(11): 1941. doi: 10.3390/genes13111941 Mohsen MO, Bachmann MF. Virus-like particle vaccinology, from bench to bedside. Cellular & Molecular Immunology. 2022; 19(9): 993-1011. doi: 10.1038/s41423-022-00897-8 Taverniti V, Ligat G, Debing Y, et al. Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives. Journal of Clinical Medicine. 2022; 11(5): 1349. doi: 10.3390/jcm11051349 Salama II, Sami SM, Salama SI, et al. Current and novel modalities for management of chronic hepatitis B infection. World Journal of Hepatology. 2023; 15(5): 585-608. doi: 10.4254/wjh.v15.i5.585 Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nature Reviews Immunology. 2021; 22(1): 19-32. doi: 10.1038/s41577-021-00549-4 Hudu S, Niazlin M, Nordin S, et al. Expression of Human Cytokine Genes Associated with Chronic Hepatitis B Disease Progression. Iranian Journal of Immunology. 2017; 14(4): 281-292. Akbar SMF, Yoshida O, Hiasa Y. Immune therapies against chronic hepatitis B. Journal of Gastroenterology. 2022; 57(8): 517-528. doi: 10.1007/s00535-022-01890-8 Aguilar J, Aguiar J, Akbar S. Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines. 2022; 10(12): 2087. doi: 10.3390/vaccines10122087 Vanwolleghem T, Adomati T, Van Hees S, et al. Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV. JHEP Reports. 2022; 4(2): 100398. doi: 10.1016/j.jhepr.2021.100398 Beretta M, Mouquet H. Advances in human monoclonal antibody therapy for HBV infection. Current Opinion in Virology. 2022; 53: 101205. doi: 10.1016/j.coviro.2022.101205 Boudewijns R, Ma J, Neyts J, et al. A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice. JHEP Reports. 2021; 3(4): 100295. doi: 10.1016/j.jhepr.2021.100295 Wang L, Zeng X, Wang Z, et al. Recent advances in understanding T cell activation and exhaustion during HBV infection. Virologica Sinica. 2023; 38(6): 851-859. doi: 10.1016/j.virs.2023.10.007 Konopleva MV, Borisova VN, Sokolova MV, et al. Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro. Vaccines. 2022; 10(2): 235. doi: 10.3390/vaccines10020235 Lei X, Cai X, Yang Y. Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines. Expert Review of Vaccines. 2020; 19(3): 235-246. doi: 10.1080/14760584.2020.1738227 Zheng P, Dou Y, Wang Q. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. Frontiers in Cellular and Infection Microbiology. 2023; 13. doi: 10.3389/fcimb.2023.1206720 Tian Y, Hu D, Li Y, et al. Development of therapeutic vaccines for the treatment of diseases. Molecular Biomedicine. 2022; 3(1). doi: 10.1186/s43556-022-00098-9 Yoshida O, Akbar SMF, Imai Y, et al. Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical study. Hepatology Research. 2022; 53(3): 196-207. doi: 10.1111/hepr.13851 Su J, Brunner L, Ates Oz E, et al. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models. Journal of Hepatology. 2023; 78(4): 717-730. doi: 10.1016/j.jhep.2022.12.013 Aguiar Santiago JA, Marrero Miragaya MA, Figueroa Oliva DA, et al. Preparing for the Next Pandemic: Increased Expression of Interferon-Stimulated Genes After Local Administration of Nasalferon or HeberNasvac. DNA and Cell Biology. 2024; 43(2): 95-102. doi: 10.1089/dna.2023.0283 Shiraishi K, Yoshida O, Imai Y, et al. Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders. Vaccines. 2023; 11(9): 1479. doi: 10.3390/vaccines11091479 Zhang S, Yan C, Millar DG, et al. Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy. Cancer Research. 2021; 82(5): 773-784. doi: 10.1158/0008-5472.can-21-2200 Srivastava M, Copin R, Choy A, et al. Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues. Frontiers in Immunology. 2022; 13. doi: 10.3389/fimmu.2022.1032716 Yamamoto Y, Kanayama N, Nakayama Y, et al. Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease. Journal of Personalized Medicine. 2022; 12(3): 444. doi: 10.3390/jpm12030444 Salmon DA, Dudley MZ, Brewer J, et al. LetsTalkShots: personalized vaccine risk communication. Frontiers in Public Health. 2023; 11. doi: 10.3389/fpubh.2023.1195751 Jain KK. Personalized therapy of Infectious Diseases. In: Textbook of Personalized Medicine. Springer International Publishing; 2021. doi: 10.1007/978-3-030-62080-6 Poria R, Kala D, Nagraik R, et al. Vaccine development: Current trends and technologies. Life Sciences. 2024; 336: 122331. doi: 10.1016/j.lfs.2023.122331 Zhang Y, Bourgine M, Wan Y, et al. Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers. Journal of Hepatology. 2024; 80(1): 31-40. doi: 10.1016/j.jhep.2023.09.019 Sacherl J, Kosinska AD, Kemter K, et al. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance. JHEP Reports. 2023; 5(2): 100603. doi: 10.1016/j.jhepr.2022.100603 Chang ML, Liaw YF. Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure. Drugs. 2023; 83(5): 367-388. doi: 10.1007/s40265-023-01843-2 Yardeni D, Chang KM, Ghany MG. Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure. Gastroenterology. 2023; 164(1): 42-60.e6. doi: 10.1053/j.gastro.2022.10.008 Poria R, Kala D, Nagraik R, et al. Vaccine development: Current trends and technologies. Life Sciences. 2024; 336: 122331. doi: 10.1016/j.lfs.2023.122331 Campos-Valdez M, Monroy-Ramírez HC, Armendáriz-Borunda J, et al. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability. Viruses. 2021; 13(6): 1167. doi: 10.3390/v13061167 Zaki MYW, Fathi AM, Samir S, et al. Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. Cancers. 2022; 14(5): 1255. doi: 10.3390/cancers14051255 Liu Y, Park D, Cafiero T, et al. Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses. Innovation in Hepatology. 2022; 4(9): 100535. doi: 10.1016/j.jhepr.2022.100535 Said Z, El-Sayed M. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World Journal of Hepatology. 2022; 14(7): 1333-1343. doi: 10.4254/wjh.v14.i7.1333 Lok AS, Pan CQ, Han S-HB, et al. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. Journal of Hepatology. 2016; 65(3): 509-516. doi: 10.1016/j.jhep.2016.05.016 Lobaina Y, Aguilar JC, Guillen G. ABX203, a novel therapeutic vaccine for chronic hepatitis B patients. Almanac of Clinical Medicine. 2016; 44(6): 713–718. doi: 10.18786/2072-0505-2016-44-6-713-718 Wei L, Zhao T, Zhang J, et al. Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial. Hepatology. 2021; 75(1): 182-195. doi: 10.1002/hep.32109 Li T, Qian C, Gu Y, et al. Current progress in the development of prophylactic and therapeutic vaccines. Science China Life Sciences. 2023; 66(4): 679-710. doi: 10.1007/s11427-022-2230-4 Lim SG, Baumert TF, Boni C, et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nature Reviews Gastroenterology & Hepatology. 2023; 20(4): 238-253. doi: 10.1038/s41575-022-00724-5 Hudu SA, Shinkafi SH, Umar S. An overview of recombinant vaccine technology, adjuvants and vaccine delivery methods. International Journal of Pharmacy and Pharmaceutical Sciences. 2016; 8(11): 19-24. doi: 10.22159/ijpps.2016v8i11.14311 Khan N, Almajed MR, Fitzmaurice MG, et al. Developments in pharmacotherapeutic agents for hepatitis B–how close are we to a functional cure? Expert opinion on pharmacotherapy. 2023; 24(9): 1001-1011. doi: 10.1080/14656566.2023.2211259 Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. Journal of Hepatology. 2023; 79(2): 516-537. doi: 10.1016/j.jhep.2023.03.017 Laupèze B, Vassilev V, Badur S. A role for immune modulation in achieving a functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology. 2023; 17(11): 1135-1147. doi: 10.1080/17474124.2023.2268503 Uwishema O, Nchasi G, Nnko GG, et al. The insight through the current immunotherapeutic guidelines for infectious diseases. International Journal of Surgery. 2023; 109(1): 71-72. doi: 10.1097/JS9.0000000000000152 Adugna A. Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection. Journal of Inflammation Research. 2023; 2159-2166. doi: 10.2147/JIR.S411492 Tapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. Jama. 2023; 329(18): 1589-1602. doi: 10.1001/jama.2023.5997 Farlow A, Torreele E, Gray G, et al. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Vaccines. 2023; 11(3): 690. doi: 10.3390/vaccines11030690 Lu H, Cao W, Zhang L, et al. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity. Frontiers in Immunology. 2023; 14: 1122048. doi: 10.3389/fimmu.2023.1122048 Maqsood Q, Sumrin A, Iqbal M, et al. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives. Antiviral Therapy. 2023; 28(4): 13596535231189643. doi: 10.1177/13596535231189643 Umemura T, Wattanakamolkul K, Nakayama Y, et al. Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database. Infectious Diseases and Therapy. 2023; 12(5): 1337-1349. doi: 10.1007/s40121-023-00795-0 Feld J, Lok A, Zoulim F. New perspectives on the development of curative strategies for chronic hepatitis B. Clinical Gastroenterology and Hepatology. 2023; S1542-3565. doi: 10.1016/j.cgh.2023.02.032 Haddad-Boubaker S, Mbarek H, Yassine H. Personalized medicine and infectious disease management. Frontiers in Medicine. 2023; 10: 1191147. doi: 10.3389/fmed.2023.1191147 Kumar M, Pahuja S, Khare P, et al. Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus. Diagnostics. 2023; 13(3): 368-368. doi: 10.3390/diagnostics13030368